SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-20-000051
Filing Date
2020-11-12
Accepted
2020-11-12 08:20:39
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myov-20200930.htm   iXBRL 10-Q 1522689
2 EX-10.1 a09302020myovantex101.htm EX-10.1 409730
3 EX-10.2 a09302020myovantex102.htm EX-10.2 297163
4 EX-10.3 a09302020myovantex103.htm EX-10.3 55694
5 EX-10.4 a09302020myovantex104.htm EX-10.4 13130
6 EX-10.5 a09302020myovantex105.htm EX-10.5 138642
7 EX-10.6 a09302020myovantex106.htm EX-10.6 102474
8 EX-10.7 a09302020myovantex107.htm EX-10.7 80788
9 EX-31.1 myovantex31109302020.htm EX-31.1 10678
10 EX-31.2 myovantex31209302020.htm EX-31.2 10872
11 EX-32.1 myovantex32109302020.htm EX-32.1 6431
12 EX-32.2 myovantex32209302020.htm EX-32.2 6273
18 image_01.jpg GRAPHIC 27559
19 image_01a.jpg GRAPHIC 167
20 image_03.jpg GRAPHIC 27559
  Complete submission text file 0001679082-20-000051.txt   7144026

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20200930.xsd EX-101.SCH 40771
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20200930_cal.xml EX-101.CAL 70626
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20200930_def.xml EX-101.DEF 199939
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20200930_lab.xml EX-101.LAB 467032
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20200930_pre.xml EX-101.PRE 314687
21 EXTRACTED XBRL INSTANCE DOCUMENT myov-20200930_htm.xml XML 825297
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 201303551
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences